Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$16.45 - $25.88 $3,290 - $5,176
-200 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$22.67 - $28.01 $4,534 - $5,602
200 New
200 $5,000
Q4 2020

Feb 12, 2021

SELL
$12.16 - $19.77 $2,432 - $3,954
-200 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$11.25 - $14.75 $2,250 - $2,950
200 New
200 $3,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.